Abstract
Objective: Canada introduced a mandatory folic acid food fortification program in November 1998. We investigated whether the rate of folate and vitamin B12 insufficiency among adults has changed since this mandatory fortification program was implemented.
Methods: We conducted a retrospective cross-sectional study using a large Ontario laboratory database. We included all individuals who underwent evaluation of their serum folate, red cell folate and serum vitamin B12 between April 1, 1997 to July 31, 1998 (Period A), August 1, 1998 to January 30, 1999 (Period B) and February 1, 1999 to March 31, 2000 (Period C).
Results: A total of 8,884 consecutive samples were analyzed during the period of study. Mean age was 57.4 years (SD 21.1), and 63.2% were female. The prevalence of serum folate insufficiency (below 3.4 nmol/L) fell from 0.52% in Period A to 0.22% in Period C [prevalence ratio (RR) 0.41, 95% confidence interval (CI) 0.18–0.93)]. The prevalence of red cell folate insufficiency (below 215 nmol/L) declined from 1.78% during Period A to 0.41% in Period C (RR 0.23, 95% CI 0.14–0.40). No significant difference was observed between periods in the prevalence of B12 insufficiency below 120 pmol/L (3.93% versus 3.11%, respectively; RR 0.79, 95% CI 0.62–1.01).
Conclusions: There has been a significant decline in the prevalence of folate, but not vitamin B12 insufficiency, following Canadian folic acid food fortification. These changes may have important implications for the prevention and detection of folate and vitamin B12 insufficiency, including identifying the benefits of folic acid food fortification and the need to further consider fortification or supplementation with vitamin B12.
Résumé
Objectif: En novembre 1998, le Canada a lancé un programme d’enrichissement en acide folique obligatoire pour certains aliments. Nous avons voulu déterminer si le taux de carence en folate et en vitamine B12 chez les adultes a changé depuis la mise en oeuvre du programme.
Méthode: Étude transversale rétrospective à partir d’une vaste base de données d’un laboratoire ontarien. Nous avons inclus toutes les personnes dont le folate sérique, le folate érythrocytaire et la vitamine B12 sérique ont été évalués entre le 1er avril 1997 et le 31 juillet 1998 (période A), entre le 1er août 1998 et le 30 janvier 1999 (période B) et entre le 1er février 1999 et le 31 mars 2000 (période C).
Résultats: En tout, 8 884 échantillons consécutifs ont été analysés durant la période de référence. L’âge moyen des sujets était de 57,4 ans (déviation sensible [DS] de 21,1), et 63,2 % étaient des femmes. Le taux de carence en folate sérique (< 3,4 nmol/L) a reculé, passant de 0,52 % pendant la période A à 0,22 % pendant la période C [ratio des taux de prévalence (RT) = 0,41, intervalle de confiance (IC) de 95 % = 0,18-0,93)]. Le taux de carence en folate érythrocytaire (< 215 nmol/L) a également baissé, passant de 1,78 % pendant la période A à 0,41 % pendant la période C (RT = 0,23, IC de 95 % = 0,14-0,40). Nous n’avons observé aucune différence significative d’une période à l’autre pour les taux de carence en vitamine B12 (< 120 pmol/L) (3,93 % contre 3,11 %, respectivement; RT = 0,79, IC de 95 % = 0,62-1,01).
Conclusions: Il y a eu une baisse significative du taux de carence en folate, mais non en vitamine B12, depuis l’augmentation de l’enrichissement en acide folique au Canada. Les changements observés pourraient avoir des conséquences importantes pour la prévention et la détection des carences en folate et en vitamine B12, en permettant notamment de déterminer les avantages de l’enrichissement des aliments en acide folique et la nécessité d’étudier plus avant l’enrichissement ou la supplémentation en vitamine B12.
Similar content being viewed by others
References
Koren G. Folic acid and neural tube defects. Good news at last! Can Fam Phys 1999;45:2605–6.
Ray JG, Cole DE, Boss, SC. An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: Is a preventable public health issue on the rise? Clin Biochem 2000;33:337–43.
Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526–33.
Halsted, CH. The intestinal absorption of dietary folates in health and disease. J Am Coll Nutr 1989;8:650–58.
Brussaard JH, Lowik MR, van den Berg H, Brants HA, Goldbohm, RA. Folate intake and status among adults in the Netherlands. Eur J Clin Nutr 1997;51 Suppl3:S46–50.
Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification? Lancet 1999;354:915–16.
Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg, IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449–54.
Cuskelly GJ, McNulty H, Scott, JM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: Implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70:234–39.
Jen P, Woo B, Rosenthal PE, Bunn HF, Loscalzo A, Goldman L. The value of the peripheral blood smear in anemic inpatients. The laboratory’s reading versus a physician’s reading. Arch Intern Med 1983;143:1120–25.
Robinson AR, Mladenovic J. Lack of utility of folate levels in the evaluation of macrocytosis or anemia. Am J Med 2001;110:88–90.
Snow, CF. Laboratory diagnosis of vitamin B12 and folate insufficiency. A guide for the primary care physician. Arch Intern Med 1999;159:1289–98.
Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum vitamin B12, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: Ethnic and sex differences in vitamin B12 and metabolite abnormalities. Am J Clin Nutr 1999;70:904–10.
Mills, JL. Fortification of foods with folic acid — how much is enough? N Engl J Med 2000;19:1442–45.
Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317–23.
Brown CA, McKinney KQ, Kaufman JS, Gravel RA, Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 2000;7:197–200.
Langman LJ, Keren ES, Miner SES, Mamer OA, Evrovski J, Ross HJ, Cole DEC. The effects of increased folate on cobalamin in cardiac transplant patients. Clin Chem 2000;46S:A110.
Brouwer DA, Welten HT, Reijngoud DJ, van Doormaal JJ, Muskiet, FA. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine. Clin Chem 1998;44:1545–50.
Campbell, NR. How safe are folic acid supplements? Arch Intern Med 1996;156:1638–44.
Rauma AL, Torronen R, Hanninen O, Mykkanen H. Vitamin B-12 status of long-term adherents of a strict uncooked vegan diet (“living food diet”) is compromised. J Nutr 1995;125:2511–15.
Oakley GP Jr. Let’s increase folic acid fortification and include vitamin B-12 (letter). Am J Clin Nutr 1997;65:1889–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ray, J.G., Vermeulen, M.J., Boss, S.C. et al. Declining Rate of Folate Insufficiency Among Adults Following Increased Folic Acid Food Fortification in Canada. Can J Public Health 93, 249–253 (2002). https://doi.org/10.1007/BF03405010
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03405010